First Bank & Trust’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Other funds holding BIIB
First Bank & Trust's BIIB Position: Q1 2024 in Review
First Bank & Trust sold out of Biogen (BIIB) in Q1 2024, closing a stake of 784 shares — an estimated $203K sold.
First Bank & Trust first reported a position in BIIB in Q1 2019 and held it in 20 quarters. The position peaked at $349K in Q1 2020. 955 funds tracked by Wall St. Rank hold BIIB as of Q1 2024.
- First Bank & Trust reported no remaining Biogen position as of Q1 2024 after selling out during the quarter.
- First Bank & Trust sold 784 Biogen shares in Q1 2024, an estimated $203K.
- First Bank & Trust first reported a position in Biogen in Q1 2019 and held it in 20 quarters.
- First Bank & Trust's Biogen position peaked at $349K in Q1 2020.
- 955 funds tracked by Wall St. Rank held Biogen as of Q1 2024.
Based on First Bank & Trust's 13F filing for Q1 2024, filed 17 Apr 2024.